Firm News
Greg Carlin and Kim Davis Publish
August 14, 2011
The article discusses a recent case heard by the United States Court of Appeals for the Federal Circuit (CAFC), Cancer Research Technology, Ltd. v. Barr Laboratories (CRT v. Barr). Carlin and Davis summarize the current state of the law on prosecution laches in view of CRT v. Barr and provide guidelines for practitioners needing to balance client needs with equitable obligations of timely prosecution.
The article appears in Volume 18, Issue 2 of Georgia State University’s Journal of Intellectual Property Law. View
Related Insights
MCC Announces Attorneys Ranked in Best Lawyers
Several Meunier Carlin & Curfman (“MCC”) attorneys received recognition in the 2025 edition of The Best Lawyers in America. Chris...
READ
MORE
MCC Reaffirms Mansfield Committment
Meunier Carlin & Curfman LLC (“MCC”) announces that the firm is reaffirming its commitment to Mansfield Certification for 2024-2025. Since...
READ
MORE
Join Us for a Webinar on Utilizing JPO’s Collective Examination
Meunier Carlin & Curfman invites you to a webinar on April 23rd at 11am EST on “Comprehensive Protection of Your...
READ
MORE